This systematic review evaluates the efficacy and safety of duodenal-jejunal bypass liner for the treatment for patients with obesity (class I and higher) with/without type 2 diabetes mellitus.
The duodenal-jejunal bypass liner is a minimal-invasive method to reduce body weight and to control type 2 diabetes mellitus. The technology consists of a 60 cm sleeve, which is endoscopically delivered into the duodenum and a small part of the jejunum.